According to Global Blue Group's latest financial reports the company's current revenue (TTM) is $0.43 B. In 2022 the company made a revenue of $0.27 B an increase over the years 2021 revenue that were of $0.11 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.43 B | 58.82% |
2022 | $0.27 B | 145.29% |
2021 | $0.11 B | -14.91% |
2020 | $0.13 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 21,145.55% | ๐บ๐ธ USA |
Medtronic MDT | $32.32 B | 7,281.65% | ๐ฎ๐ช Ireland |
Boston Scientific BSX | $14.24 B | 3,152.31% | ๐บ๐ธ USA |
Edwards Lifesciences EW | $6.00 B | 1,271.45% | ๐บ๐ธ USA |
Stryker Corporation SYK | $20.49 B | 4,581.59% | ๐บ๐ธ USA |